Sinopharm
1099.HK
#2722
Rank
โ‚ฌ5.79 B
Marketcap
1,86ย โ‚ฌ
Share price
-1.35%
Change (1 day)
-10.42%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚ฌ71.22 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚ฌ71.22 Billion. In 2025 the company made a revenue of โ‚ฌ71.22 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ69.38 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚ฌ71.22 B2.65%
2024โ‚ฌ69.38 B-5.1%
2023โ‚ฌ73.11 B5.42%
2022โ‚ฌ69.35 B-2.1%
2021โ‚ฌ70.83 B16.85%
2020โ‚ฌ60.62 B14.95%
2019โ‚ฌ52.73 B21.52%
2018โ‚ฌ43.39 B5.93%
2017โ‚ฌ40.96 B27.22%
2016โ‚ฌ32.20 B5.37%
2015โ‚ฌ30.55 B9.14%
2014โ‚ฌ27.99 B17.22%
2013โ‚ฌ23.88 B25.94%
2012โ‚ฌ18.96 B34.61%
2011โ‚ฌ14.09 B55.34%
2010โ‚ฌ9.07 B35.79%
2009โ‚ฌ6.67 B37.56%
2008โ‚ฌ4.85 B31.43%
2007โ‚ฌ3.69 B40.26%
2006โ‚ฌ2.63 B